These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 15051763

  • 1. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
    Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V.
    J Exp Med; 2004 Apr 05; 199(7):947-57. PubMed ID: 15051763
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
    Miyamoto K, Miyake S, Yamamura T.
    Nature; 2001 Oct 04; 413(6855):531-4. PubMed ID: 11586362
    [Abstract] [Full Text] [Related]

  • 4. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
    Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y.
    J Immunol; 1998 Dec 15; 161(12):6480-6. PubMed ID: 9862671
    [Abstract] [Full Text] [Related]

  • 5. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
    Roy KC, Maricic I, Khurana A, Smith TR, Halder RC, Kumar V.
    J Immunol; 2008 Mar 01; 180(5):2942-50. PubMed ID: 18292516
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
    Rhost S, Löfbom L, Rynmark BM, Pei B, Månsson JE, Teneberg S, Blomqvist M, Cardell SL.
    Eur J Immunol; 2012 Nov 01; 42(11):2851-60. PubMed ID: 22777932
    [Abstract] [Full Text] [Related]

  • 8. Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury.
    Ström A, Wigren M, Hultgårdh-Nilsson A, Saxena A, Gomez MF, Cardell S, Fredrikson GN, Nilsson J.
    Circ Res; 2007 Oct 12; 101(8):e83-9. PubMed ID: 17885216
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, MacDonald HR.
    J Immunol; 1999 Jun 01; 162(11):6410-9. PubMed ID: 10352254
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
    Miyake S, Yamamura T.
    Int Rev Immunol; 2007 Jun 01; 26(1-2):73-94. PubMed ID: 17454265
    [Abstract] [Full Text] [Related]

  • 12. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, Gui M, Taniguchi M, Hayakawa K, Kronenberg M.
    J Immunol; 1998 Oct 01; 161(7):3271-81. PubMed ID: 9759842
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL.
    Clin Exp Immunol; 2006 Feb 01; 143(2):194-202. PubMed ID: 16412042
    [Abstract] [Full Text] [Related]

  • 18. Recognition of pollen-derived phosphatidyl-ethanolamine by human CD1d-restricted gamma delta T cells.
    Russano AM, Agea E, Corazzi L, Postle AD, De Libero G, Porcelli S, de Benedictis FM, Spinozzi F.
    J Allergy Clin Immunol; 2006 May 01; 117(5):1178-84. PubMed ID: 16675349
    [Abstract] [Full Text] [Related]

  • 19. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells.
    Pál E, Tabira T, Kawano T, Taniguchi M, Miyake S, Yamamura T.
    J Immunol; 2001 Jan 01; 166(1):662-8. PubMed ID: 11123351
    [Abstract] [Full Text] [Related]

  • 20. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
    Sundell IB, Halder R, Zhang M, Maricic I, Koka PS, Kumar V.
    J Stem Cells; 2010 Jan 01; 5(1):33-42. PubMed ID: 20861926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.